Effect of a deacyl gymnemic acid on glucose homeostasis & metabolic parameters in a rat model of metabolic syndrome

Indian Journal of Medical Research

Volumn 137, Issue 6, 2013, Pages 1174-1179

  Bhansali, Shobhit ^a   Shafq, Nusrat ^a   Pandhi, Promila ^a   Pal Singh, Amrit ^a   Singh, Inderjeet ^b   Singh, Pawan Kumar ^a   Sharma, Sadhna ^a   Malhotra, Samir ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Department of Herbal Extract   (India)

Author keywords

Deacyl gymnemic acid; Gymnema sylvestre; Metabolic syndrome

Indexed keywords

FRUCTOSE; GYMNEMIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PIEZOELECTRICITY; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; FRUCTOSE; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; RATS; RATS, WISTAR; SAPONINS; SYSTOLE; THIAZOLIDINEDIONES; TRIGLYCERIDES; TRITERPENES;

EID: 84879515867     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide defnition. Lancet 2005; 366: 1059-62.
2. Ford GS, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: fndings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
3. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351-5.
4. Dhurandhar NV, Kulkarni PR. Prevalence of obesity in Bombay. Int J Obes Relat Metab Disord 1992; 16: 367-75.
5. Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 2003; 61: 69-76.
6. Gupta M, Malhotra S, Chandra KK, Sharma YP, Grover A, Pandhi P. Prevalence of metabolic syndrome among patients with stable coronary artery disease. Indian J Cardiol 2003; 6: 72-6.
7. Marles RJ, Farnsworth NR. Anti-diabetic plants and their active constituents. Phytomedicine 1995; 2: 137-65.
8. Ernst E. Plants with hypoglycemic activity in humans. Phytomedicine 1997; 4: 73-8.
9. Nammi S, Sreemantula S, Roufogalis BD. Protective effects of ethanolic extract of Zingiber offcinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol 2009; 104: 366-73.
10. Shanmugasundram KR, Panneerselvam C, Samudram P, Shanmugasundaram ER. Enzyme changes and glucose utilization in diabetic rabbits: the effect of Gymnema sylvestre, R.Br. J Ethnopharmacol 1983; 7: 205-34.
11. Baskaran K, Kizar Ahamath B, Shanmugasundaram KR, Shanmugasundaram ER. Antidiabetic effect of a leaf extracts from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol 1990; 30: 295-300.
12. Prakash AO, Mathur S, Mathur R. Effect of feeding Gymnema sylvestre leaves on blood glucose in beryllium nitrate treated rats. J Ethnopharmacol 1986; 18: 143-6.
13. Okabayashi Y, Tani S, Fujisawa T, Koide M, Hasegawa H, Nakamura T, et al. Effect of Gymnema sylvestre, R.Br. on glucose homeostasis in rats. Diabetes Res Clin Pract 1990; 9: 143-8.
14. Tominaga M, Kimura M, Sugiyama K, Abe T, Igarashi K, Igarashi M, et al. Effects of seishin-renshi-in and Gymnema sylvestre on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 1995; 29: 11-7.
15. Kokate CK, Purhoit AP, Gokhale SB. Drug containing glycosides. In: Kokate CK, Purhoit AP, Gokhale SB, editors. Pharmacognosy. Mumbai, India: Nirali Prakashan; 2002. p. 167-254.
16. Buang RD, Butterfeld J. Tail cuff blood pressure measurement without external preheating in awake rats. Hypertension 1982; 4: 898-903.
17. Singh I, Singh PK, Bhansali S, Shafq N, Malhotra S, Pandhi P. Effects of three different doses of a fruit extract of Terminalia chebula on metabolic components of metabolic syndrome, in a rat model. Phytother Res 2010; 24: 107-12.
18. Korec R. Estimation of glucose by the glucose oxidase method. Cas Lek Cesk 1963; 102: 152-5.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
21. Tofovic PS, Jackson EK. Rat Models of the Metabolic Syndrome. In: Goligorsky MS, editor. Methods in molecular medicine: Renal disease: Techniques and protocols. Totowa, NJ: Human Press Inc; 2003. p. 29-46.
22. Yokozawa T, Kim HJ, Yamabe N, Okamoto T, Cho EJ. The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model. J Pharm Pharmacol 2007; 59: 1271-8.
23. Lê KA, Tappy L. Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 2006; 9: 469-75.
24. Davis SN. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Brunton LL, editor. The pharmacological basis of therapeutics. New York: McGraw-Hill; 2006. p. 1613-45.
25. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009; 42: 1331-46.
26. Shanmugasundaram ER, Gopinath KL, Shanmugasundaram KR, Rajendran VM. Possible regeneration of the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. J Ethnopharmacol 1990; 30: 265-79.
27. Svíglerová J, Kuncová J, Tonar Z. Streptozotocin-induced model of type 1 diabetes mellitus. Cesk Fysiol 2006; 55: 96-102.